UONDDL
ONCE

University of Notre Dame du Lac’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

University of Notre Dame du Lac’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-38,371
Closed -$1.97M – 93
2017
Q4 		$1.97M Buy
+38,371
New +$2.76M 0.41% 68

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

University of Notre Dame du Lac's ONCE Position: Q1 2018 in Review

University of Notre Dame du Lac sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2018, closing a stake of 38,371 shares — an estimated $1.97M sold.

University of Notre Dame du Lac first reported a position in ONCE in Q4 2017 and held it in 1 quarter. The position peaked at $1.97M in Q4 2017. 162 funds tracked by Wall St. Rank hold ONCE as of Q1 2018.

  • University of Notre Dame du Lac reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • University of Notre Dame du Lac sold 38,371 Spark Therapeutics, Inc. Common Stock shares in Q1 2018, an estimated $1.97M.
  • University of Notre Dame du Lac first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • University of Notre Dame du Lac's Spark Therapeutics, Inc. Common Stock position peaked at $1.97M in Q4 2017.
  • 162 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2018.

Based on University of Notre Dame du Lac's 13F filing for Q1 2018, filed 15 May 2018.